2 insiders bought €13k of shares over the last 90 days, the latest filed 29 Jul 2026.
This page follows insider dealings at Spago Nanomedical as filed with Finansinspektionen. Over the twelve months to 18 October 2026, 7 filings were filed, from 5 insiders.
No insider sold shares on the market over the period. Instead, the filings list 2 purchases totalling €13k, made by 2 insiders. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. One trade stands out by size: a purchase of €8,996 from Hakasan AB Hakasan AB, disclosed on 29 July 2026, or 0.13% of market capitalisation. On the buying side, the filings list 2 chief executives among the declarants.
Within a 30-day window, 1 purchase overlapped with buying by a second insider. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. The last insider purchase was made public on 29 July 2026, 80 days ago. Filings reach the Finansinspektionen feed a median of 2 days after the trade. For comparison, MAR article 19 gives managers three business days to notify a trade.
With 7 filings in twelve months, the company is in line with the median of 7 filings across the 886 companies we follow on the same exchange. Since 2021, the database holds 2 purchases and 2 sales by insiders of the company.
Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.
FY ended December 2025 · cache
9 of 9 declarations
Spago Nanomedical is a company focused on developing targeted cancer treatments using nanomedicine technologies. It is listed on the Stockholm Stock Exchange under the symbol XSTO.